- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Recent progress in pharmaceutical therapies for castration-resistant prostate cancer - Abstract
September 4, 2013
Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors - Abstract
September 4, 2013
3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization - Abstract
September 3, 2013
Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection - Abstract
September 3, 2013
The phylogeny of permanent prostate brachytherapy - Abstract
September 3, 2013
Divorcing diagnosis from treatment: Contemporary management of low-risk prostate cancer - Abstract
September 3, 2013
External validation of the Cancer of the Prostate Risk Assessment-S score in Koreans undergoing radical prostatectomy - Abstract
September 3, 2013
Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection - Abstract
September 2, 2013
Accurate patient selection and multimodal treatment offer the best therapeutic option in high-risk prostate cancer - Abstract
September 2, 2013
Current, new and novel therapy for castration-resistant prostate cancer - Abstract
September 2, 2013
Prostate cancer invasion and metastasis: Insights from mining genomic data - Abstract
September 2, 2013
3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with prostate cancer--An interobserver variability study - Abstract
September 2, 2013
The prostate-specific antigen test - Abstract
September 2, 2013
Treatment of gynecomastia in patients with prostate cancer and androgen deprivation - Abstract
September 2, 2013